Apple-53BP1trunc Citations (9)
Originally described in: Single cell resolution in vivo imaging of DNA damage following PARP inhibition.Yang KS, Kohler RH, Landon M, Giedt R, Weissleder R Sci Rep. 2015 May 18;5:10129. doi: 10.1038/srep10129. PubMed Journal
Articles Citing Apple-53BP1trunc
| Articles |
|---|
| Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression. Yuan R, Liu Q, Segeren HA, Yuniati L, Guardavaccaro D, Lebbink RJ, Westendorp B, de Bruin A. EMBO J. 2019 Oct 15;38(20):e101430. doi: 10.15252/embj.2018101430. Epub 2019 Sep 2. PubMed |
| Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity. Weigelin B, den Boer AT, Wagena E, Broen K, Dolstra H, de Boer RJ, Figdor CG, Textor J, Friedl P. Nat Commun. 2021 Sep 1;12(1):5217. doi: 10.1038/s41467-021-25282-3. PubMed |
| APOBEC3C, a nucleolar protein induced by genotoxins, is excluded from DNA damage sites. Constantin D, Dubuis G, Conde-Rubio MDC, Widmann C. FEBS J. 2022 Feb;289(3):808-831. doi: 10.1111/febs.16202. Epub 2021 Oct 4. PubMed |
Temporal dynamics of base excision/single-strand break repair protein complex assembly/disassembly are modulated by the PARP/NAD(+)/SIRT6 axis.
Koczor CA, Saville KM, Andrews JF, Clark J, Fang Q, Li J, Al-Rahahleh RQ, Ibrahim M, McClellan S, Makarov MV, Migaud ME, Sobol RW.
Cell Rep. 2021 Nov 2;37(5):109917. doi: 10.1016/j.celrep.2021.109917.
PubMed
Associated Plasmids |
| CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment. Klomp JE, Lee YS, Goodwin CM, Papke B, Klomp JA, Waters AM, Stalnecker CA, DeLiberty JM, Drizyte-Miller K, Yang R, Diehl JN, Yin HH, Pierobon M, Baldelli E, Ryan MB, Li S, Peterson J, Smith AR, Neal JT, McCormick AK, Kuo CJ, Counter CM, Petricoin EF 3rd, Cox AD, Bryant KL, Der CJ. Cell Rep. 2021 Nov 30;37(9):110060. doi: 10.1016/j.celrep.2021.110060. PubMed |
| Genetic instability from a single S phase after whole-genome duplication. Gemble S, Wardenaar R, Keuper K, Srivastava N, Nano M, Mace AS, Tijhuis AE, Bernhard SV, Spierings DCJ, Simon A, Goundiam O, Hochegger H, Piel M, Foijer F, Storchova Z, Basto R. Nature. 2022 Apr;604(7904):146-151. doi: 10.1038/s41586-022-04578-4. Epub 2022 Mar 30. PubMed |
| Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53. Segeren HA, van Liere EA, Riemers FM, de Bruin A, Westendorp B. Oncogene. 2022 May;41(19):2719-2733. doi: 10.1038/s41388-022-02291-0. Epub 2022 Apr 7. PubMed |
| Biosensor Cell-Fit-HD(4D) for correlation of single-cell fate and microscale energy deposition in complex ion beams. Schlegel J, Liew H, Rein K, Dzyubachyk O, Debus J, Abdollahi A, Niklas M. STAR Protoc. 2022 Oct 29;3(4):101798. doi: 10.1016/j.xpro.2022.101798. eCollection 2022 Dec 16. PubMed |
| The role of mitosis in generating fitness heterogeneity. Buss JH, Lenz LS, Pereira LC, Torgo D, Marcolin J, Begnini KR, Lenz G. J Cell Sci. 2023 Jan 1;136(1):jcs260103. doi: 10.1242/jcs.260103. Epub 2023 Jan 3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.